SGNTUC-019 phase 2 basket study of tucatinib and trastuzumab in solid tumors with human epidermal growth factor receptor 2 alterations: uterine and cervical cancer cohorts (327)

Journal article

Peer reviewed

Bradley Monk, Brian Alexander, Qianwen Tan and David O’Malley

Gynecologic oncology, Vol.166, p.S169

08/2022

Metrics

4 Record Views

Title: SGNTUC-019 phase 2 basket study of tucatinib and trastuzumab in solid tumors with human epidermal growth factor receptor 2 alterations: uterine and cervical cancer cohorts (327)
Creators: Bradley Monk
Brian Alexander
Qianwen Tan
David O’Malley
Publication Details: Gynecologic oncology, Vol.166, p.S169
Identifiers: 991005968882702656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article